A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
NEW research highlights the utility of the PRECISE-DAPT score in predicting gastrointestinal (GI) bleeding risk in patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary ...
PORTLAND, GA, UNITED STATES, November 20, 2024 /EINPresswire / -- The global angioplasty balloons market size was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, ...
The HeartBeam system is currently under review with the FDA. “The data presentations at AHA are a testament to HeartBeam’s dedication to building a robust body of clinical evidence to support our ...